Drug profile · INN
alfuzosin
XATRAL SR
alfuzosin (XATRAL SR) is a adrenergic receptor alpha-1 agonist. Associated with Sanofi-aventis Healthcare Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — alfuzosin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
alfuzosin (XATRAL SR) is a adrenergic receptor alpha-1 agonist. Associated with Sanofi-aventis Healthcare Pty Ltd.
Key facts
INN alfuzosin
Brand XATRAL SR
Mechanism Adrenergic receptor alpha-1 agonist
Originator Sanofi-aventis Healthcare Pty Ltd
Mechanism of action
Adrenergic receptor alpha-1 agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is alfuzosin?
alfuzosin (XATRAL SR) is a adrenergic receptor alpha-1 agonist. Associated with Sanofi-aventis Healthcare Pty Ltd.
What is the brand name for alfuzosin?
XATRAL SR is a marketed brand name for alfuzosin. Check FDA Drugs@FDA for the current US label holder and prescribing information.